Page last updated: 2024-08-26

racecadotril and Hypertension

racecadotril has been researched along with Hypertension in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brouard, R; Brunner, HR; Burnier, M; Favrat, B; Lecomte, JM; Nussberger, J; Waeber, B1
Wilkins, MR1
Hayashi, I; Ito, H; Izumi, T; Katori, M; Majima, M; Nakajima, S1
Fujimura, A; Furukawa, K; Inaba, S; Mabuchi, H; Miyamori, I; Takeda, Y1
Clerc, G; Duchier, J; Gros, C; Lecomte, JM; Lefrançois, P; Lim, C; Schwartz, JC1

Reviews

1 review(s) available for racecadotril and Hypertension

ArticleYear
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular disease.
    Biochemical Society transactions, 1993, Volume: 21 ( Pt 3), Issue:3

    Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diuretics; Drug Design; Heart Failure; Humans; Hypertension; Indans; Neprilysin; Propionates; Protease Inhibitors; Thiorphan

1993

Trials

2 trial(s) available for racecadotril and Hypertension

ArticleYear
Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Journal of hypertension, 1995, Volume: 13, Issue:7

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Neprilysin; Protease Inhibitors; Thiorphan

1995
Antihypertensive activity of sinorphan.
    Lancet (London, England), 1990, Aug-04, Volume: 336, Issue:8710

    Topics: Aged; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Thiorphan

1990

Other Studies

3 other study(ies) available for racecadotril and Hypertension

ArticleYear
Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.
    British journal of pharmacology, 1999, Volume: 126, Issue:3

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Carboxypeptidases; Cathepsin A; Desoxycorticosterone; Drinking; Heart; Heart Ventricles; Hypertension; Kallikreins; Kidney; Kinins; Lactones; Lisinopril; Male; Organ Size; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thiorphan; Time Factors; Urination; Water-Electrolyte Balance

1999
Ecadotril. (S)-acetorphan, sinorphan.
    Drugs in R&D, 1999, Volume: 1, Issue:4

    Topics: Animals; Cardiovascular Diseases; Drugs, Investigational; Endopeptidases; Heart Failure; Humans; Hypertension; Protease Inhibitors; Rats; Rats, Inbred SHR; Thiorphan

1999
Effects of chronic neutral endopeptidase inhibition in rats with cyclosporine-induced hypertension.
    Journal of hypertension, 2000, Volume: 18, Issue:7

    Topics: Animals; Blood Pressure; Blotting, Southern; Cyclosporine; DNA Probes; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Male; Natriuretic Peptide, C-Type; Neprilysin; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Protease Inhibitors; Rats; Rats, Inbred WKY; RNA, Messenger; Thiorphan

2000